These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 291752

  • 1. Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure.
    Hirota N, Williams GM.
    J Natl Cancer Inst; 1979 Nov; 63(5):1257-65. PubMed ID: 291752
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions.
    Watanabe K, Williams GM.
    J Natl Cancer Inst; 1978 Nov; 61(5):1311-4. PubMed ID: 280716
    [Abstract] [Full Text] [Related]

  • 3. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
    Katayama S, Ohmori T, Maeura Y, Croci T, Williams GM.
    J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
    [Abstract] [Full Text] [Related]

  • 4. Progressive DNA damage in hepatic nodules during 2-acetylaminofluorene carcinogenesis.
    Stout DL, Becker FF.
    Cancer Res; 1980 Apr; 40(4):1269-73. PubMed ID: 7357556
    [Abstract] [Full Text] [Related]

  • 5. Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation.
    Hirota N, Williams GM.
    Cancer Res; 1982 Jun; 42(6):2298-309. PubMed ID: 7074612
    [Abstract] [Full Text] [Related]

  • 6. Enhancing effect of inducers of liver microsomal enzymes on induction of hyperplastic liver nodules by N-2-fluorenylacetamide in rats.
    Tatematsu M, Nakanishi K, Murasaki G, Miyata Y, Hirose M, Ito N.
    J Natl Cancer Inst; 1979 Dec; 63(6):1411-6. PubMed ID: 117197
    [Abstract] [Full Text] [Related]

  • 7. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
    Furuya K, Maeura Y, Williams GM.
    Toxicol Pathol; 1984 Dec; 12(2):136-42. PubMed ID: 11478314
    [Abstract] [Full Text] [Related]

  • 8. Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low-level exposure to 2-acetylaminofluorene.
    Williams GM, Tanaka T, Maruyama H, Maeura Y, Weisburger JH, Zang E.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6224-30. PubMed ID: 1933882
    [Abstract] [Full Text] [Related]

  • 9. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
    LeBoeuf RA, Laishes BA, Hoekstra WG.
    Cancer Res; 1985 Nov 01; 45(11 Pt 1):5489-95. PubMed ID: 2865004
    [Abstract] [Full Text] [Related]

  • 10. Persistence of resistant putative preneoplastic hepatocytes induced by N-nitrosodiethylamine or N-methyl-N-nitrosourea.
    Solt DB, Cayama E, Sarma DS, Farber E.
    Cancer Res; 1980 Apr 01; 40(4):1112-8. PubMed ID: 7357542
    [Abstract] [Full Text] [Related]

  • 11. Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen.
    Williams GM, Watanabe K.
    J Natl Cancer Inst; 1978 Jul 01; 61(1):113-21. PubMed ID: 276621
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of polyprenoic acid (E-5166) on N-2-fluorenylacetamide-initiated hepatocarcinogenesis in rats.
    Shima H, Kuniyasu T, Sugie S, Tanaka T, Mori H, Takahashi M, Muto Y.
    Jpn J Cancer Res; 1986 Apr 01; 77(4):351-5. PubMed ID: 3084425
    [Abstract] [Full Text] [Related]

  • 14. Unscheduled DNA synthesis in cells from N-2-fluorenylacetamide-induced hyperplastic nodules of rat liver maintained in a primary culture system.
    Kitagawa T, Michalopoulos G, Pitot HC.
    Cancer Res; 1975 Dec 01; 35(12):3682-92. PubMed ID: 1238166
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis.
    Garcea R, Daino L, Pascale R, Simile MM, Puddu M, Frassetto S, Cozzolino P, Seddaiu MA, Gaspa L, Feo F.
    Cancer Res; 1989 Apr 01; 49(7):1850-6. PubMed ID: 2564313
    [Abstract] [Full Text] [Related]

  • 17. Enhanced survival and absence of progressive growth of transplanted rat liver altered eosinophilic foci and neoplastic nodules in phenobarbital-treated rats.
    Mori H, Furuya K, Williams GM.
    J Natl Cancer Inst; 1983 Oct 01; 71(4):849-54. PubMed ID: 6194334
    [Abstract] [Full Text] [Related]

  • 18. Increase of T cells in the liver during hepatocarcinogenesis with N-2-fluorenylacetamide in rats.
    Okita K, Ando K, Fukumoto Y, Miyazaki M, Tsubota W, Kodama T, Takemoto T.
    Gan; 1981 Aug 01; 72(4):610-4. PubMed ID: 7030859
    [Abstract] [Full Text] [Related]

  • 19. Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies.
    Dunsford HA, Karnasuta C, Hunt JM, Sell S.
    Cancer Res; 1989 Sep 01; 49(17):4894-900. PubMed ID: 2474377
    [Abstract] [Full Text] [Related]

  • 20. Distribution of alpha-fetoprotein- and albumin-containing cells in the livers of Fischer rats fed four cycles of N-2-fluorenylacetamide.
    Sell S.
    Cancer Res; 1978 Sep 01; 38(9):3107-13. PubMed ID: 79445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.